학술논문

Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis from the Randomized Phase II ELOQUENT-3 Trial

Document Type

Article

Author

Dimopoulos, M.A.; Dytfeld, D.; Grosicki, S.; Moreau, P.; Takezako, N.; Hori, M.; Leleu, X.; Leblanc, R.; Suzuki, K.; Raab, M.S.; Richardson, P.G.; Popa McKiver, M.; Jou, Y.-M.; Yao, D.; Das, P.; San-Miguel, J.

Source

In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 20 January 2023, 41(3):568-578)

Subject

Language

English

ISSN

15277755
0732183X

Online Access

Full Text (ASCO/JCO) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송